ArticleInternational journal of cancer2026
Rising Incidence and Mortality of Colorectal Cancer Among Younger Adults: A Population-Based Study in Taiwan, 1994-2018.
Article in International journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) incidence and mortality have increased significantly in the Asia-Pacific region over the past three decades. Taiwan is not reported but presents one of the globally highest age-standardized EOCRC incidence and mortality rates. This population-based study in Taiwan from 1994 to 2018 examines changing CRC epidemiology among younger adults (aged 15-29 and 30-49 years) and older adults (aged ≥ 50 years). Age-period-cohort modeling (APC) and average annual percentage change (AAPC) analyses indicated that the elevated risk of age-standardized EOCRC incidence and mortality was primarily driven by the aged 30-49-year-old cohort, whereas only modest increases were observed in adults aged ≥ 50 years. Significant cohort effects were observed in the APC analysis, with annual increases of 3580 and 1000 per 100,000 in incidence and mortality, respectively, among the 30-49-year-old cohort, compared with increases of 2600 and 800 per 100,000, respectively, in the ≥ 50-year-old cohort. Furthermore, participants aged 15-29 years were more frequently diagnosed at stages 3 and 4, resulting in a 7.8% lower survival rate compared with the 30-49-year-old cohort. The key risk factors unique to younger patients with CRC are summarized, highlighting the urgent need for tailored policy interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.